“Using Modern Technology to Surveil, Monitor, and Diagnose Infectious Disease”
Fisher Healthcare presents…”Using Modern Technology to Surveil, Monitor, and Diagnose Infectious Disease”
There is a growing need for accurate and timely information about the status of infectious disease in a community, county or state. Such information will alert physicians, hospital administrators, medical and laboratory directors, and public health agencies, and can enable preventive measures and/or improved patient care and management. Modern surveillance technology shows great promise in fulfilling this need by sending results in near real-time for influenza, RSV, and Strep A tests to the CDC, state departments of health, and healthcare organizations nation-wide.
This webinar will discuss recent technological advances that have afforded certain FDA-cleared rapid point of care instruments that aid in the diagnosis of infectious disease the capability to wirelessly convey near real-time results and transmit to public health agencies and organizations for use in de-identified surveillance and laboratory management. The utility for laboratory management, featuring quality control, training, resource management, and operator performance will be discussed, as will the impact of valid real-time data on the management of patients and the timely and appropriate use of antivirals and antibiotics. Promising new applications of data in developing enhanced disease forecasting and the benefits this promises for public health, healthcare systems, pharmacies and others will be also be considered.
- Identify technology that allows certain FDA-cleared, rapid-POC testing instruments to wirelessly transmit to public authorities
- Describe how labs can use the technology for quality control, training and resource management
- Analyze the impact of valid real-time data on patient care management, including the use of antivirals and antibiotics
- Discuss promising new applications of data to enhance disease forecasting and its benefits for various stakeholders
John Tamerius, Ph.D. – Sr. Vice President, Strategic and External Affairs, Quidel Corp.
Target audience: Lab
Continuing education credit information:
- 1 P.A.C.E.® credit-hour will be provided for this complimentary basic level program.
Whitehat Communications is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program.
- This session is approved for 1 Florida Laboratory CE credit. Florida Board of Clinical Laboratory Personnel approved number: 50-12563
There is no cost associated with this program.